Gruticibart
古瑞西拜单抗
Report date: 2026/03/30 20:02:02
Base Information
Drug NameGruticibart
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOregon Health & Science University
China Registration ClassN/A
Develop Information
Active CompaniesOhsu Knight Cancer Institute
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A